Amgen Future Growth
Future criteria checks 1/6
Amgen is forecast to grow earnings and revenue by 1.4% and 5.4% per annum respectively while EPS is expected to grow by 2.9% per annum.
Key information
1.4%
Earnings growth rate
2.9%
EPS growth rate
Biotechs earnings growth | 42.4% |
Revenue growth rate | 5.4% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 16 Oct 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 32,497 | 7,468 | 10,517 | 11,267 | 18 |
12/31/2024 | 31,697 | 7,737 | 10,293 | 10,704 | 20 |
12/31/2023 | 27,368 | 7,575 | 9,660 | 11,098 | 23 |
6/30/2023 | 26,582 | 7,979 | 9,685 | 10,800 | N/A |
3/31/2023 | 26,190 | 7,917 | 7,531 | 8,621 | N/A |
12/31/2022 | 26,323 | 6,552 | 8,785 | 9,721 | N/A |
9/30/2022 | 26,330 | 6,835 | 8,997 | 9,880 | N/A |
6/30/2022 | 26,384 | 6,576 | 8,355 | 9,320 | N/A |
3/31/2022 | 26,316 | 5,723 | 8,417 | 9,321 | N/A |
12/31/2021 | 25,979 | 5,893 | 8,381 | 9,261 | N/A |
9/30/2021 | 25,767 | 5,609 | 7,840 | 8,606 | N/A |
6/30/2021 | 25,484 | 5,746 | 8,897 | 9,556 | N/A |
3/31/2021 | 25,164 | 7,085 | 9,835 | 10,467 | N/A |
12/31/2020 | 25,424 | 7,264 | 9,889 | 10,497 | N/A |
9/30/2020 | 24,987 | 7,352 | 10,235 | 10,858 | N/A |
6/30/2020 | 24,301 | 7,299 | 10,209 | 10,867 | N/A |
3/31/2020 | 23,966 | 7,675 | 8,795 | 9,439 | N/A |
12/31/2019 | 23,362 | 7,842 | 8,532 | 9,150 | N/A |
9/30/2019 | 23,395 | 8,067 | 9,175 | 9,830 | N/A |
6/30/2019 | 23,562 | 7,958 | 9,070 | 9,726 | N/A |
3/31/2019 | 23,750 | 8,075 | 9,715 | 10,414 | N/A |
12/31/2018 | 23,747 | 8,394 | 10,558 | 11,296 | N/A |
9/30/2018 | 23,319 | 2,202 | 10,448 | 11,114 | N/A |
6/30/2018 | 23,188 | 2,364 | 10,642 | 11,295 | N/A |
3/31/2018 | 22,939 | 2,219 | 10,868 | 11,519 | N/A |
12/31/2017 | 22,849 | 1,979 | 10,513 | 11,177 | N/A |
9/30/2017 | 23,012 | 8,178 | 10,527 | 11,265 | N/A |
6/30/2017 | 23,050 | 8,174 | 9,825 | 10,473 | N/A |
3/31/2017 | 22,928 | 7,893 | N/A | 10,824 | N/A |
12/31/2016 | 22,991 | 7,722 | N/A | 10,354 | N/A |
9/30/2016 | 22,562 | 7,587 | N/A | 9,327 | N/A |
6/30/2016 | 22,474 | 7,433 | N/A | 9,557 | N/A |
3/31/2016 | 22,156 | 7,216 | N/A | 10,164 | N/A |
12/31/2015 | 21,662 | 6,939 | N/A | 9,731 | N/A |
9/30/2015 | 21,457 | 6,433 | N/A | 10,103 | N/A |
6/30/2015 | 20,765 | 5,814 | N/A | 9,952 | N/A |
3/31/2015 | 20,575 | 5,708 | N/A | 8,895 | N/A |
12/31/2014 | 20,063 | 5,158 | N/A | 8,952 | N/A |
9/30/2014 | 19,743 | 4,885 | N/A | 7,945 | N/A |
6/30/2014 | 19,460 | 5,009 | N/A | 7,011 | N/A |
3/31/2014 | 18,959 | 4,720 | N/A | 6,384 | N/A |
12/31/2013 | 18,676 | 5,081 | N/A | 6,291 | N/A |
9/30/2013 | 17,980 | 4,848 | N/A | 5,268 | N/A |
6/30/2013 | 17,551 | 4,587 | N/A | 5,184 | N/A |
3/31/2013 | 17,349 | 4,595 | N/A | 5,959 | N/A |
12/31/2012 | 17,265 | 4,345 | N/A | 5,882 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1AMGN's forecast earnings growth (1.4% per year) is below the savings rate (2.2%).
Earnings vs Market: 1AMGN's earnings (1.4% per year) are forecast to grow slower than the Italian market (6.3% per year).
High Growth Earnings: 1AMGN's earnings are forecast to grow, but not significantly.
Revenue vs Market: 1AMGN's revenue (5.4% per year) is forecast to grow faster than the Italian market (-0.2% per year).
High Growth Revenue: 1AMGN's revenue (5.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1AMGN's Return on Equity is forecast to be high in 3 years time